Results

Total Results: 1,331 records

Showing results for "response".

1. Published Comment and Response: Comparing the USPSTF and GRADE Approaches to Recommendations | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/published-comment-and-response-comparing-uspstf-and-grade-approaches-recommendations
   February 01, 2014 - Published Comment and Response: Comparing the USPSTF and GRADE Approaches to Recommendations … Table of Contents Comment Response Comment TO THE EDITOR: In their article on the "insufficient … [PMID: 18497416] Response IN RESPONSE: The USPSTF welcomes this opportunity to further explicate … PMID: 18483053] Current as of: September 2009 Internet Citation:   Published Comment and Response

2. Archived: Published Response - Will Recommendations against Spirometry Make Chronic Obstructive Pulmonary Disease Harder to Treat?: Chronic Obstructive Pulmonary Disease (COPD): Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/published-response---will-recommendations-against-spirometry-make-chronic-obstructive-pulmonary-disease-harder-to-treat/chronic-obstructive-pulmonary-disease-copd-screening
   November 15, 2008 - archived Published Response - Will Recommendations against Spirometry Make Chronic Obstructive … Table of Contents Response References Expand All … Response IN RESPONSE: We appreciate the letter from Drs.

3. Archived: Published Response - Will Recommendations against Spirometry Make Chronic Obstructive Pulmonary Disease Harder to Treat?: Chronic Obstructive Pulmonary Disease (COPD): Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/published-response---will-recommendations-against-spirometry-make-chronic-obstructive-pulmonary-disease-harder-to-treat/chronic-obstructive-pulmonary-disease-copd-screening-2008
   November 15, 2008 - Share to WhatsApp Share to Email Print archived Published Response … Table of Contents Response References Expand All … Response IN RESPONSE

4. Archived: Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/published-comment-and-response-do-lipid-lowering-agents-provide-a-greater-reduction-in-cardiovascular-events-among-patients-with-diabetes/diabetes-mellitus-type-2-in-adults-screening
   November 15, 2008 - archived Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction … [PMID: 18519930] Response IN RESPONSE: In making its recommendation on screening

5. Archived: Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/published-comment-and-response-do-lipid-lowering-agents-provide-a-greater-reduction-in-cardiovascular-events-among-patients-with-diabetes/diabetes-mellitus-type-2-in-adults-screening-2008
   November 15, 2008 - WhatsApp Share to Email Print archived Published Comment and Response … [PMID: 18519930] Response … IN RESPONSE: In making its recommendation on screening for type 2 diabetes, the USPSTF considered

6. Final Research Plan: Skin Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/skin-cancer-screening
   March 25, 2021 - dermatoscopy, whole body photography) KQ1: Lesion-directed diagnostic skin examination (e.g., in response … Covered in 2018 evidence review on behavioral counseling for skin cancer prevention. 1 Response … In response to public comment, the USPSTF clarified the wording of KQs 2 and 4 to more clearly delineate … skin cancer, clarified that the exclusion of “lesion-directed diagnostic skin examination (e.g., in response

7. Final Research Plan: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hepatitis-c-screening
   December 21, 2017 - the effectiveness of currently recommended antiviral treatments in achieving a sustained virologic response … What is the association between improvement of sustained virologic response following antiviral treatment … regimen; includes clinical trials without a comparison group   Outcomes Sustained virologic response … , studies not reporting original data Association between improvements in sustained virologic response … Response to Public Comment

8. Final Research Plan: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-anxiety-children-adolescents
   March 29, 2022 - of benefit to patients) for symptoms and functioning on the most common instruments used to measure response … Response to Public Comment … In response, the USPSTF edited the key questions to remove the qualifier “increased risk of suicide” … One commenter suggested excluding clomipramine because it is not a first-line therapy; in response, we … Commenters suggested several outcomes; in response, we have clarified that we will include validated

9. Final Research Plan: Depression and Suicide Risk in Children and Adolescents: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-depression-suicide-risk-children-adolescents
   August 13, 2020 - of benefit to patients) for symptoms and functioning on the most common instruments used to measure response … Response to Public Comment … In response, the USPSTF edited the key questions to remove the qualifier “increased risk of suicide” … One commenter suggested excluding clomipramine because it is not a first-line therapy; in response, we … Commenters suggested several outcomes; in response, we have clarified that we will include validated

10. Final Research Plan: Skin Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan104/skin-cancer-screening
    July 17, 2014 - examination (e.g., dermatoscopy, whole body photography) Diagnostic skin examinations in response … reports and case series (except as noted for KQs 2 and 6); decision analyses   Response … Public response was largely favorable toward the proposed research approach. … In response to specific comments, the USPSTF revised the inclusion and exclusion criteria to include

11. Archived: Final Research Plan: Skin Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan104/skin-cancer-screening-july-2016
    July 17, 2014 - examination (e.g., dermatoscopy, whole body photography) Diagnostic skin examinations in response … reports and case series (except as noted for KQs 2 and 6); decision analyses   Response … Public response was largely favorable toward the proposed research approach. … In response to specific comments, the USPSTF revised the inclusion and exclusion criteria to include

12. Final Research Plan: Eating Disorders in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-eating-disorders-adolescents-adults
    September 24, 2020 - Response to Public Comment … In response, the USPSTF added two additional groups based on a rationale for how these factors may affect … In response, the USPSTF added text to clarify that interventions designed for primary prevention only … In response, the USPSTF recommended being inclusive of studies that offer multicomponent interventions

13. Procedure Manual Appendix VI. Criteria for Assessing Internal Validity of Individual Studies | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-vi-criteria-assessing-internal-validity-individual-studies
    July 01, 2017 - of cases Nonbiased selection of cases/controls, with exclusion criteria applied equally to both Response … selection of case and control participants; exclusion criteria applied equally to cases and controls; response … Fair: Recent, relevant, and without major apparent selection or diagnostic workup bias, but response … Poor: Major selection or diagnostic workup bias, response rate less than 50%, or inattention to confounding

14. Archived: Evidence Summary: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary29/hepatitis-b-virus-infection-screening-may-2014
    May 27, 2014 - Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine … Germany, Poland, Spain, United Kingdom, United States 83 14 75 Positive NR Biochemical response … Fair Zeng et al, 2006 25 RCT 12 wk China 480 32 83 Positive NR Biochemical response … , HBeAg loss/seroconversion, virologic response, mortality Fair Interferon-α2b vs. no treatment … * 40 patients had no virologic response and were excluded from the analysis.

15. Archived: Evidence Summary: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary29/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
    May 27, 2014 - Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine … Germany, Poland, Spain, United Kingdom, United States 83 14 75 Positive NR Biochemical response … Fair Zeng et al, 2006 25 RCT 12 wk China 480 32 83 Positive NR Biochemical response … , HBeAg loss/seroconversion, virologic response, mortality Fair Interferon-α2b vs. no treatment … * 40 patients had no virologic response and were excluded from the analysis.

16. Archived: Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review: Hepatitis C: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/comparative-effectiveness-of-antiviral-treatment-for-hepatitis-c-virus-infection-in-adults-a-systematic-review/hepatitis-c-screening-2013
    November 15, 2012 - One trial ( n  = 1088) found response-guided triple therapy with telaprevir (triple therapy for 8 or … One trial found response-guided therapy with telaprevir for 24 to 48 weeks was associated with higher … Response-guided telaprevir combination treatment for hepatitis C virus infection. … A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. … factors predicting response.

17. Final Research Plan: Gynecological Conditions: Periodic Screening With the Pelvic Examination | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan137/gynecological-conditions-screening-with-the-pelvic-examination
    March 05, 2015 - In response to a topic nomination from the public, the USPSTF has commissioned a review of the evidence … statistical models that extrapolate beyond direct clinical evidence; poor-quality studies Response … In response, the USPSTF added the rectovaginal examination to the included interventions. … The USPSTF also made minor clarifications to the inclusion and exclusion criteria in response to various

18. Archived: Final Evidence Summary: Vitamin D and Calcium to Prevent Fractures: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
    December 10, 2011 - Results of Linear Mixed-Effects Meta-Regression to Examine the Dose–Response Relationships Between … The ranges of blood 25-(OH)D concentrations and the shapes of the dose-response relationships varied … Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. … Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. … Go to the Appendix for methods used for the dose–response meta-analyses.

19. Evidence Summary: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-anxiety-children-adolescents
    October 11, 2022 - Main Outcomes and Measures: Test accuracy, symptoms, response, remission, loss of diagnosis, all-cause … CBT was also associated with a favorable clinical response (pooled relative risk [RR], 1.89 [95% CI, … Pharmacotherapy was also associated with a favorable clinical response (pooled RR, 2.11 [95% CI, 1.58 … Two studies reported on response, and both reported statistically significant differences favoring CBT … Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS

20. Archived: Final Research Plan: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan23/hepatitis-b-virus-infection-screening-may-2014
    March 15, 2013 - Response to Public Comment Expand All Preface The final … Response to Public Comment The draft Research Plan was posted for public comment on the U.S … The Research Plan was revised in response to these comments.